HAP Trading’s Adverum Biotechnologies ADVM Stock Holding History

HAP Trading’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,319	Closed	-$399K	–	1211
2019 Q3	$399K	Buy	+7,319	New	+$825K	0.03%	350

Other funds holding ADVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HAP Trading's ADVM Position: Q4 2019 in Review

HAP Trading sold out of Adverum Biotechnologies (ADVM) in Q4 2019, closing a stake of 7,319 shares — an estimated $399K sold.

HAP Trading first reported a position in ADVM in Q3 2019 and held it in 1 quarter. The position peaked at $399K in Q3 2019. 116 funds tracked by Wall St. Rank hold ADVM as of Q4 2019.

HAP Trading reported no remaining Adverum Biotechnologies position as of Q4 2019 after selling out during the quarter.
HAP Trading sold 7,319 Adverum Biotechnologies shares in Q4 2019, an estimated $399K.
HAP Trading first reported a position in Adverum Biotechnologies in Q3 2019 and held it in 1 quarter.
HAP Trading's Adverum Biotechnologies position peaked at $399K in Q3 2019.
116 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.